These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14768782)

  • 1. Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure.
    Málek F; Dvorák J; Jiresová E; Spacek R
    Cent Eur J Public Health; 2003 Dec; 11(4):198-201. PubMed ID: 14768782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum copper levels in patients with chronic heart failure associated with systolic left ventricular dysfunction and its relation to the severity of cardiac failure].
    Málek F; Spacek R; Polásek R; Karel L; Stanka P; Zenáhlíková M; Jiresová E
    Vnitr Lek; 2001 Nov; 47(11):753-6. PubMed ID: 11795180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-invasive prognostic parameters in chronic heart failure].
    Spinar J; Vítovec J; Spinarová L; Toman J
    Vnitr Lek; 1996 Jan; 42(1):43-8. PubMed ID: 8629360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].
    Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M
    Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.
    Stanton EB; Hansen MS; Sole MJ; Gawad Y; Packer M; Pitt B; Swedberg K; Rouleau JL;
    Can J Cardiol; 2005 Jan; 21(1):39-43. PubMed ID: 15685301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure.
    Smilde TD; Hillege HL; Navis G; Voors AA; Brouwer J; van Veldhuisen DJ
    Int J Cardiol; 2006 Feb; 107(1):73-7. PubMed ID: 16337501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience of an outpatient heart failure clinic].
    Nassiacos D; Meloni S
    Ital Heart J; 2005 May; 6 Suppl 1():51S-65S. PubMed ID: 15945300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.
    Windram JD; Loh PH; Rigby AS; Hanning I; Clark AL; Cleland JG
    Am Heart J; 2007 Jun; 153(6):1048-55. PubMed ID: 17540208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass grafting in patients with severe left ventricular dysfunction--early and mid-term outcomes.
    Shapira OM; Hunter CT; Anter E; Bao Y; DeAndrade K; Lazar HL; Shemin RJ
    J Card Surg; 2006; 21(3):225-32. PubMed ID: 16684046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
    Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
    Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
    Kawai K; Kawashima S; Miyazaki T; Tajiri E; Mori M; Kitazaki K; Shirotani T; Inatome T; Yamabe H; Hirata K; Yokoyama M
    J Cardiol; 2010 Jan; 55(1):99-107. PubMed ID: 20122555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical ventricular remodeling for patients with clinically advanced congestive heart failure and severe left ventricular dysfunction.
    Patel ND; Barreiro CJ; Williams JA; Bonde PN; Waldron M; Natori S; Bluemke DA; Conte JV
    J Heart Lung Transplant; 2005 Dec; 24(12):2202-10. PubMed ID: 16364872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
    Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
    Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum copper as a marker of inflammation in prediction of short term outcome in high risk patients with chronic heart failure.
    Malek F; Jiresova E; Dohnalova A; Koprivova H; Spacek R
    Int J Cardiol; 2006 Nov; 113(2):e51-3. PubMed ID: 16843542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.